Trials / Enrolling By Invitation
Enrolling By InvitationNCT06405295
Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy and safety of different adjuvant intensification regimens in early-stage BRCA1/2 mutant triple-negative breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | Observation of the prognosis of patients with different standard treatment protocols in the clinic without intervention |
Timeline
- Start date
- 2024-05-06
- Primary completion
- 2029-03-01
- Completion
- 2029-05-01
- First posted
- 2024-05-08
- Last updated
- 2025-02-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06405295. Inclusion in this directory is not an endorsement.